Lepu Biotech reigns in $131mm via Series A round
Lepu Biotechnology Co. Ltd. (immuno-oncology division of Lepu Medical Technology (Beijing) Co. Ltd.) raised $131mm through its Series A round from investors including Shiyu Capital (lead), Suzhou Mingtou, Sumin Investment, China Development Bank, Suzhou Shareate Group, and the company's parent Lepu Medical.
- Large Molecule
- Venture Financing
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.